Revised Protocol No.: 04 Date: 31-May-2019 152 Approved 5.0 v Approved 1.0 v Clinical Protocol CA021002 BMS-986226 anti-ICOS Revised Protocol No.: 04 Date: 31-May-2019 153 Approved 5.0 v Approved 1.0 v Clinical Protocol CA021002 BMS-986226 anti-ICOS 11 REFERENCES 1Scott AM, Allison JP, Wolchok JD. Monoclonal antibodies in cancer therapy.